Zetia and Niaspan
Links shared publicly online about this topic
Niaspan tops Zetia in new setback for Merck drug | Reuters
reuters.com — “* Niaspan leads to reduction in artery wall thickness * No meaningful change seen with Zetia * 5 times as many serious adverse events seen with Zetia * Journal editorials cite several limitations” View full resource at reuters.com
Most Recently Shared on November 15, 2009 at 11:13 pm By:
Niaspan tops Zetia in new setback for Merck drug - Reuters http://bit.ly/1A1zvP
UPDATE 2-Niaspan tops Zetia in new setback for Merck drug | Reuters
reuters.com — “* Niaspan leads to reduction in artery wall thickness * No meaningful change seen with Zetia * 5 times as many serious adverse events seen with Zetia * Journal editorials cite several limitations” View full resource at reuters.com
Most Recently Shared on November 16, 2009 at 12:44 am By:
UPDATE 2-Niaspan tops Zetia in new setback for Merck drug - Reuters http://bit.ly/oIV29
UPDATE 3-Niaspan tops Zetia in new setback for Merck drug | Reuters
reuters.com — “* Niaspan leads to reduction in artery wall thickness * No meaningful change seen with Zetia * 5 times as many serious adverse events seen with Zetia * Journal editorials cite several limitations” View full resource at reuters.com
Most Recently Shared on November 16, 2009 at 2:27 am By:
UPDATE 3-Niaspan tops Zetia in new setback for Merck drug - Reuters http://ow.ly/161V5K
UPDATE 2-Niaspan tops Zetia in new setback for Merck drug | Reuters
reuters.com — “* Niaspan leads to reduction in artery wall thickness * No meaningful change seen with Zetia * 5 times as many serious adverse events seen with Zetia * Journal editorials cite several limitations” View full resource at reuters.com
Most Recently Shared on November 15, 2009 at 11:39 pm By:
Niaspan vs Zetia trial a blow for Merck's cholesterol business, but maybe not a knock-out one http://tinyurl.com/ylzuy6v #AHA2009
Zetia in the news again
theheart.org — “Wall Street is forecasting a win for extended-release niacin, but one clinician says the results do not mean a bust for Vytorin. Instead, he says, the results add to the existing literature that lowering LDL and raising HDL cholesterol contribute independently to cardiovascular disease risk.” View full resource at theheart.org
Most Recently Shared on August 19, 2009 at 6:47 pm By:
heartwire: Wall Street predicting win for extended-release niacin, but results not in yet http://bit.ly/4AJK0h
RPT-UPDATE 3-Niaspan tops Zetia in new setback for Merck drug | Reuters
reuters.com — “* Niaspan leads to reduction in artery wall thickness * No meaningful change seen with Zetia * 5 times as many serious adverse events seen with Zetia * Journal editorials cite several limitations” View full resource at reuters.com
Most Recently Shared on November 16, 2009 at 2:31 pm By:
RPT-UPDATE 3-Niaspan tops Zetia in new setback for Merck drug - Reuters http://ow.ly/1621xi
Niaspan May Have Outperformed Zetia in a Recently Halted Trial - Health Blog - WSJ
urlborg.com — “Several analysts are reporting that Niaspan outperformed Zetia in a recently halted trial.” View full resource at urlborg.com
Most Recently Shared on August 18, 2009 at 5:46 pm By:
Questions raised about Zetia in new study
healthcentral.com — “Questions raised about Zetia in new study” View full resource at healthcentral.com
Most Recently Shared on November 17, 2009 at 9:42 pm By:
CholesterolNetwork: Questions raised about Zetia in new study http://bit.ly/32p4ld Full http://bit.ly/nk8J0
Merck cholesterol scrips drop as Niaspan rises - FiercePharma
fiercepharma.com — “Last week, all eyes were on Merck's cholesterol drugs. How did Zetia do in that much-anticipated study pitting it against Abbott Laboratories' Niaspan treatment? Well, the American Heart Association... Read more...” View full resource at fiercepharma.com
Most Recently Shared on November 25, 2009 at 7:09 pm By:
Merck cholesterol scrips drop as Niaspan rises http://bit.ly/8k6LeZ
Merck Statement on Zetia Mess Is a Masterpiece of Spin | BNET Pharma Blog | BNET
industry.bnet.com — “You might be forgiven for thinking that Abbott Labs (ABT)’s Niaspan trounced Merck (MRK)’s Zetia in a trial known as “Arbiter 6 HALT” View full resource at industry.bnet.com
Most Recently Shared on November 16, 2009 at 6:02 pm By:
Merck Statement on Zetia Mess Is a Masterpiece of Spin http://bit.ly/1arCgI
New Study Raises New Questions About Cholesterol Drug Zetia - Drugs.com MedNews
drugs.com — “A new study raises more questions about ezetimibe (Zetia), a drug used by millions of Americans in tandem with statins to lower LDL, or bad, cholesterol. The tr” View full resource at drugs.com
Most Recently Shared on November 16, 2009 at 6:10 pm By:
New Study Raises New Questions About Cholesterol Drug Zetia - http://bit.ly/ufFTI
New Study Raises New Questions About Cholesterol Drug Zetia - US News and World Report
health.usnews.com — “It was found less effective than extended-release niacin, or Niaspan” View full resource at health.usnews.com
Most Recently Shared on November 16, 2009 at 3:32 pm By:
New Study Raises New Questions About Cholesterol Drug Zetia - U.S. News & World Report http://ow.ly/1622kj
Study Raises New Questions About Cholesterol Drug Zetia - myOptumHealth
myoptumhealth.com — “Read the news article Study Raises New Questions About Cholesterol Drug Zetia at www.myOptumHealth.com” View full resource at myoptumhealth.com
Most Recently Shared on November 16, 2009 at 12:08 pm By:
New Study Raises New Questions About Cholesterol Drug Zetia: It was found less effective than extended-release niac... http://bit.ly/28oBWa
How does Zetia and niacin affect the carotid intima-media thickness (CIMT)? | KevinMD.com
kevinmd.com — “By a margin of 0.014 mm in carotid intima-media thickness (CIMT), extended-release niacin (Niaspan) demonstrated superiority over ezetimibe (Zetia) as an add-on for high risk patients on long term statin therapy.” View full resource at kevinmd.com
Most Recently Shared on November 22, 2009 at 8:02 pm By:
RT @tweetmeme How does Zetia and niacin affect the carotid intima-media thickness (CIMT)? | KevinMD.com http://bit.ly/8RsbEa
Merck’s Cholesterol Pill Woes May Intensify on Loss to Abbott’s Niaspan
industry-news.org — “By Shannon Pettypiece Nov. 16 (Bloomberg) -- A finding that Merck & Co.’s cholesterol pills Vytorin and Zetia didn’t reopen clogged arteries as well as Abbott Laboratories ’ Niaspan has set off a medical debate on heart treatment strategies. In the trial, researchers reported finding a reduction in the thickness of artery walls in patients given Niaspan, while those on Zetia had no change. Artery thickness is believed to be a predictor of risk in heart attack and stroke because it restrict” View full resource at industry-news.org
Most Recently Shared on November 16, 2009 at 9:32 pm By:
Merck's Cholesterol Pill Woes May Intensify on Loss to Abbott's ... http://bit.ly/1VSFXb
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
low sodium foods
Healthy Heart Market - Your Online Low Sodium Food Market
-
low sodium foods
Healthy Heart Market - Your Online Low Sodium Food Market
-
Health Feed
Heath News & Information
Advertisement

